Filing Flows › Volitionrx (VNRX) › Q2 2026 › vs Q1 2026
Volitionrx (VNRX) Q2 2026 vs Q1 2026 (quarter over quarter)
Volitionrx's revenue fell $586K (-60%) from $985K in Q1 2026 to $399K in Q2 2026.
Volitionrx, Q2 2026: revenue $399K (-2% year over year), net loss $7.3M, operating cash flow −$5.2M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $399K | $985K | −$586K | -60% |
| Net loss | $7.3M | $6.7M | $612K | +9% |
| Costs & expenses | $7.7M | $7.7M | $25K | +0.3% |
| Operating costs | $4.6M | $6.3M | −$1.8M | -28% |
| Interest & other, net | $3.2M | $1.4M | $1.8M | +133% |
| Research & development | $1.8M | $2.9M | −$1.1M | -37% |
| Sales & marketing | $549K | $852K | −$303K | -36% |
| General & admin | $2.2M | $2.6M | −$424K | -16% |
| Operating cash sources | $7.3M | $6.7M | $612K | +9% |
| Depreciation & amortization | $188K | $207K | −$19K | -9% |
| Share-based compensation | $238K | $225K | $13K | +6% |
| Working capital & other | $1.7M | $991K | $739K | +75% |
| Cash used in operations | $5.2M | $5.3M | −$120K | -2% |
| Net loss absorbed | $7.3M | $6.7M | $612K | +9% |
Questions
How much did Volitionrx's revenue grow quarter over quarter in Q2 2026?
Volitionrx's revenue fell $586K (-60%) from $985K in Q1 2026 to $399K in Q2 2026.